Literature DB >> 27815184

The primary hyperoxalurias: A practical approach to diagnosis and treatment.

Sally-Anne Hulton1.   

Abstract

Although the primary hyperoxalurias (PH) are rare disorders, they are of considerable clinical importance in relation to calcium oxalate urolithiasis and as a cause of renal failure worldwide. Three distinct disorders have been described at the molecular level. The investigation of any child or adult presenting with urinary tract stones or nephrocalcinosis, must exclude PH as an underlying cause. This paper provides a practical approach to the investigation and diagnosis of PH, indicating the importance of distinguishing between the PH types for the purposes of targeting appropriate therapy. Conservative management is explored and the various transplant options are discussed. Crown
Copyright © 2016. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcium oxalate; Nephrocalcinosis; Primary hyperoxaluria; Renal stone; Urolithiasis

Mesh:

Substances:

Year:  2016        PMID: 27815184     DOI: 10.1016/j.ijsu.2016.10.039

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  8 in total

Review 1.  Novel therapeutic approaches for the primary hyperoxalurias.

Authors:  Ruth Belostotsky; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2020-11-06       Impact factor: 3.714

Review 2.  The genetics of kidney stone disease and nephrocalcinosis.

Authors:  Prince Singh; Peter C Harris; David J Sas; John C Lieske
Journal:  Nat Rev Nephrol       Date:  2021-12-14       Impact factor: 28.314

Review 3.  Personalized Intervention in Monogenic Stone Formers.

Authors:  Lucas J Policastro; Subodh J Saggi; David S Goldfarb; Jeffrey P Weiss
Journal:  J Urol       Date:  2017-10-20       Impact factor: 7.450

4.  Structural and chemical heterogeneities of primary hyperoxaluria kidney stones from pediatric patients.

Authors:  Yuan Du; Vincent Blay Roger; Jorge Mena; Misun Kang; Marshall L Stoller; Sunita P Ho
Journal:  J Pediatr Urol       Date:  2020-11-20       Impact factor: 1.830

5.  Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria.

Authors:  Chengjung Lai; Natalie Pursell; Jessica Gierut; Utsav Saxena; Wei Zhou; Michael Dills; Rohan Diwanji; Chaitali Dutta; Martin Koser; Naim Nazef; Rachel Storr; Boyoung Kim; Cristina Martin-Higueras; Eduardo Salido; Weimin Wang; Marc Abrams; Henryk Dudek; Bob D Brown
Journal:  Mol Ther       Date:  2018-06-15       Impact factor: 11.454

6.  Primary hyperoxaluria in Italy: the past 30 years and the near future of a (not so) rare disease.

Authors:  Giorgia Mandrile; Alessandra Pelle; Veronica Sciannameo; Elisa Benetti; Maria Michela D'Alessandro; Francesco Emma; Giovanni Montini; Licia Peruzzi; Michele Petrarulo; Renato Romagnoli; Corrado Vitale; Barbara Cellini; Daniela Giachino
Journal:  J Nephrol       Date:  2022-02-26       Impact factor: 3.902

Review 7.  Improving Treatment Options for Primary Hyperoxaluria.

Authors:  Bernd Hoppe; Cristina Martin-Higueras
Journal:  Drugs       Date:  2022-07-02       Impact factor: 11.431

8.  Recurrent primary hyperoxaluria type 2 leads to early post-transplant renal function loss: A case report.

Authors:  Si Liu; Baoshan Gao; Gang Wang; Weigang Wang; Xin Lian; Shan Wu; Jinyu Yu; Yaowen Fu; Honglan Zhou
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.